Date Filed | Type | Description |
02/07/2020 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
01/30/2019 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
10/30/2018 |
SC 13G/A
| INGALLS & SNYDER VALUE PARTNERS L P reports a 9.7% stake in MOSYS, INC. |
05/11/2018 |
SC 13G/A
| INGALLS & SNYDER VALUE PARTNERS L P reports a 8.3% stake in MOSYS, INC. |
02/09/2018 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
02/14/2017 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
03/22/2016 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
04/18/2013 |
SC 13G
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals |
02/07/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/07/2012 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
06/07/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/24/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/11/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
02/09/2011 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
11/29/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
08/25/2010 |
SC 13G/A
| CORCEPT THERAPEUTICS INC reports a 4.7% stake in CORCEPT THERAPEUTICS, INC |
05/06/2010 |
SC 13G
| CORCEPT THERAPEUTICS INC reports a 5% stake in CORCEPT THERAPEUTICS, INC |
02/11/2010 |
SC 13G/A
| Form SC 13G - Statement of acquisition of beneficial ownership by individuals [amend] |
01/12/2010 |
SC 13G/A
| ALSERES PHARMACEUTICALS INC reports a 9.9% stake in ALSERES PHARMACEUTICALS, INC |
01/30/2009 |
SC 13G/A
| Form SC 13G/A -- Statement of acquisition of beneficial ownership by individuals [amend] |
01/30/2009 |
SC 13G/A
| INGALLS & SNYDER VALUE PARTNERS L P reports a 6.9% stake in BIG SKY ENERGY CORPORATION |
01/28/2009 |
SC 13G/A
| INGALLS & SNYDER VALUE PARTNERS L P reports a 0% stake in FOCUS ENHANCEMENTS INC. |
01/23/2009 |
SC 13G/A
| INGALLS & SNYDER VALUE PARTNERS L P reports a 9.3% stake in ANTIGENICS INC. |
02/06/2007 |
REGDEX
| Form REGDEX -- Notice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933] |
04/25/2005 |
4/A
| Form 4/A - Statement of changes in beneficial ownership of securities [Amend] |
04/25/2005 |
4
| INGALLS & SNYDER VALUE PARTNERS L P (10% Owner) has filed a Form 4 on OGLEBAY NORTON CO /OHIO/
Txns:
| Bought 50,000 convertible preferred
@ $10, valued at
$500k
|
|
09/30/2003 |
4/A
| INGALLS & SNYDER VALUE PARTNERS L P (10% Owner) has filed a Form 4 on BOSTON LIFE SCIENCES INC /DE
Txns:
| Acquired 207,167 options to buy
@ $1, valued at
$207.2k
|
|
09/30/2003 |
4
| INGALLS & SNYDER VALUE PARTNERS L P (10% Owner) has filed a Form 4 on BOSTON LIFE SCIENCES INC /DE
Txns:
| Acquired 207,167 options to buy
@ $1, valued at
$207.2k
|
|
01/22/2003 |
REGDEX
| Form REGDEX -- Notice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933] Effectiveness Date: 2003-01-17 |
01/22/2002 |
REGDEX
| Form REGDEX -- Notice of Sale of Securities [Regulation D and Section 4(6) of the Securities Act of 1933] |
04/06/1999 |
4
| Form 4 - Statement of changes in beneficial ownership of securities |